SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-042934
Filing Date
2015-07-17
Accepted
2015-07-17 06:01:56
Documents
5
Period of Report
2015-08-26
Effectiveness Date
2015-07-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A v415485_def14a.htm DEF 14A 398639
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC v415485_pc1.jpg GRAPHIC 676361
5 GRAPHIC v415485_pc2.jpg GRAPHIC 468201
  Complete submission text file 0001144204-15-042934.txt   1977676
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36641 | Film No.: 15992624
SIC: 2836 Biological Products, (No Diagnostic Substances)